General Info

Dr. Schnadig specializes in genitourinary (GU) malignancies, general adult oncology and hematology. He is very active in The US Oncology Research Network, serving as a member of the national GU Research Committee and as principal investigator for many Phase II and Phase III studies. As GU Chair of the US Oncology Pathways Task Force, he is responsible for developing GU cancer treatment guidelines for physicians nationally. These facts speak to Dr. Schnadiga's practice philosophy of applying the most current and innovative thinking to help patients choose therapies and clinical trials targeted to their specific tumor characteristics.